Protox Therapeutics Inc. (TSX-V: PRX) will
hold an investor conference call to discuss the progress of the company's
prostate cancer and benign prostatic hyperplasia (BPH) programs on Monday,
March 13th at 1:00p.m. PST (4:00p.m. EST). To participate on the call, please
dial 604-899-1159 or 1-888-458-1598 before 1:00 p.m. PST (access code 27319).
A replay of the call will be available via the Internet at
www.protoxtherapeutics.com and also via telephone at 1-877-653-0545 (access
code 310769).
